Immunocore Holdings plc

IMCRNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$400.0M

▲ 29.0% YoY

Net Income

-$35.5M

▲ 30.5% YoY

EPS

$-0.71

▲ 30.4% YoY

Cash

$467.7M

▲ 2.6% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.